Related Experiment Video
Updated: Jul 17, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Transactivation of Src, PDGF receptor, and Akt is involved in IL-1beta-induced ICAM-1 expression in A549 cells
Chih-Chung Lin1, Chiang-Wen Lee, Tzu-Hua Chu
1Department of Anesthetics, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan.
Abstract:
In previous study, interleukin-1beta (IL-1beta) has been shown to induce ICAM-1 expression through MAPKs and NF-kappaB in A549 cells. In addition to these pathways, transactivation of non-receptor tyrosine kinase (Src), PDGF receptors (PDGFRs), and phosphatidylinositol 3-kinase (PI3K)/Akt has been implicated in the expression of inflammatory genes. Here, we further investigated whether these different mechanisms participating in IL-1beta-induced ICAM-1 expression in A549 cells. We initially observed that IL-1beta-induced ICAM-1 promoter activity was attenuated by the inhibitors of Src (PP1), PDGFR (AG1296), PI3-K (LY294002 and wortmannin), and Akt (SH-5), revealed by reporter gene assay, Western blotting, and RT-PCR analyses. The involvement of Src and PI3-K/Akt in IL-1beta-induced ICAM-1 expression was significantly attenuated by transfection of A549 cells with dominant negative plasmids of Src, p85 and Akt, respectively. Src, PDGFR, and PI3K/Akt mediated the effects of IL-1beta because pretreatment with PP1, AG1296, and wortmannin also abrogated IL-1beta-stimulated Src, PDGFR, and Akt phosphorylation, respectively. Moreover, pretreatment with p300 inhibitor (curcumin) also blocked ICAM-1 expression. We further confirmed that p300 was associated with ICAM-1 promoter which was dynamically linked to histone H4 acetylation stimulated by IL-1beta, determined by chromatin immunoprecipitation assay. Association of p300 and histone-H4 to ICAM-1 promoter was inhibited by LY294002. Up-regulation of ICAM-1 enhanced the adhesion of neutrophils onto A549 cell monolayer exposed to IL-1beta, which was inhibited by PP1, AG1296, LY294002, wortmannin, and helenalin. These results suggested that Akt phosphorylation mediated through transactivation of Src/PDGFR promotes the transcriptional p300 activity and eventually leads to ICAM-1 expression induced by IL-1beta.
Insights
Interleukin-1beta (IL-1beta) induces ICAM-1 expression via Src, PDGFR, and PI3K/Akt pathways, involving p300 transcriptional activity and histone acetylation. This pathway enhances neutrophil adhesion, which is inhibited by blocking these signaling molecules.
Area of Science:
- Cellular and Molecular Biology
- Immunology
- Biochemistry
Background:
- Interleukin-1beta (IL-1beta) is a key inflammatory cytokine.
- IL-1beta induces ICAM-1 expression, crucial for immune cell adhesion.
- Previous studies implicated MAPKs and NF-kappaB in IL-1beta-induced ICAM-1 expression.
Purpose of the Study:
- To investigate the role of non-receptor tyrosine kinase (Src), PDGF receptors (PDGFRs), and PI3K/Akt pathways in IL-1beta-induced ICAM-1 expression in A549 cells.
- To elucidate the downstream molecular mechanisms, including p300 activity and histone acetylation, involved in this process.
- To assess the functional consequence of ICAM-1 upregulation on neutrophil adhesion.
Main Methods:
- Reporter gene assays, Western blotting, and RT-PCR to analyze ICAM-1 expression and promoter activity.
- Transfection with dominant-negative plasmids for Src, p85, and Akt.
- Chromatin immunoprecipitation (ChIP) assays to determine protein-DNA interactions and histone modifications.
- Inhibition studies using specific pathway inhibitors (PP1, AG1296, LY294002, wortmannin, SH-5, curcumin, helenalin).
Main Results:
- Inhibitors of Src, PDGFR, PI3-K, and Akt attenuated IL-1beta-induced ICAM-1 promoter activity.
- Dominant-negative Src, p85, and Akt significantly reduced IL-1beta-induced ICAM-1 expression.
- IL-1beta-stimulated phosphorylation of Src, PDGFR, and Akt was abrogated by pathway inhibitors.
- p300 inhibition blocked ICAM-1 expression, and p300 association with the ICAM-1 promoter correlated with histone H4 acetylation.
- LY294002 inhibited the association of p300 and histone-H4 with the ICAM-1 promoter.
- Upregulated ICAM-1 enhanced neutrophil adhesion, which was reversed by pathway inhibitors.
Conclusions:
- Akt phosphorylation, mediated by Src/PDGFR transactivation, promotes IL-1beta-induced ICAM-1 expression in A549 cells.
- The Src/PDGFR/PI3K/Akt pathway regulates ICAM-1 expression through p300 transcriptional coactivator activity and histone H4 acetylation.
- Targeting these signaling pathways can inhibit IL-1beta-induced ICAM-1 expression and subsequent neutrophil adhesion.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
IP3/DAG Signaling Pathway
MAPK Signaling Cascades
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
